KAREN LOWE: Open Payments
NPI 1598184590 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 23 payments from 6 companies in 2025. Trend: 2023 $269 · 2024 $160 · 2025 $498
Food & beverage: $411Education: $87
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 4 | $249 |
| ABBVIE INC. | 14 | $149 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Electromed, Inc. | 2 | $25 |
| Baxter Healthcare | 1 | $16 |
Products named: ZENPEP, CREON, ZERBAXA, EMBLAVEO, SMARTVEST, PERCLOT.
Industry payments across TX — which companies pay providers there.
